Table VI.
Anti-compression biomechanical evaluation of the femoral condyle in the presence of a composite material with, or without, SA (n=4).
| Week 6a | Week 8b | |||
|---|---|---|---|---|
| Composite material | Load (N) | Strength (MPa) | Load (N) | Strength (MPa) |
| GS/DBM/PLA (with SA) | 288.284±31.255 | 12.012±1.302 | 363.029±23.828 | 15.126±0.993 |
| DBM/PLA (with SA) | 192.376±15.811c | 8.01±0.659c | 248.687±21.465c | 10.362±0.894c |
| DBM/PLA (without SA) | 322.530±32.802d | 13.439±1.367d | 412.902±11.748a,d | 17.204±0.490c,d |
| Normal control group | 88.696±22.174c,d,e | 17.651±1.012c,d,e | 527.878±33.655c,d,e | 21.995±1.402c,d,e |
a
F-value, 50.381
b
F-value, 93.291
c
P<0.05 vs. non-operated control group
d
P<0.05 vs. GS/DBM/PLA
e
P<0.05 vs. DBM/PLA. GS, gentamicin sulfate; DBM, demineralized bone matrix; PLA, polylactic acid.